Americans Can’t Buy the Top-Notch Sunscreen That Europeans Have Been Using for Years

The best sunburn protections are blocked by a federal backlog, but Congress is pushing legislation it says will clear the way.

National Journal
Sophie Novack
Add to Briefcase
See more stories about...
Sophie Novack
April 7, 2014, 10:04 a.m.

Sun­screens that have been avail­able in Europe and oth­er for­eign mar­kets for years re­main banned from U.S. stores be­cause of a back­log in the fed­er­al bur­eau­cracy.

The in­gredi­ents that make the sun­screen su­per­i­or have been await­ing ap­prov­al — or any sort of de­cision — from the Food and Drug Ad­min­is­tra­tion for at least 12 years. There are cur­rently eight such in­gredi­ents stuck in the sys­tem.

Without ac­cess to the in­gredi­ents, con­sumers may be blocked from buy­ing the sun­screens that provide the most ef­fect­ive pro­tec­tions against harm­ful rays.

Con­gress has a plan to break the 12-year back­log: The House En­ergy and Com­merce Com­mit­tee on Monday is look­ing at le­gis­la­tion that would ex­ped­ite the FDA’s ap­prov­al pro­cess for sun­screen in­gredi­ents. Should the pan­el ap­prov­al the meas­ure, it would put the bill one step closer to pas­sage.

A com­pan­ion ver­sion of the House bill is pending with the Sen­ate’s Health Com­mit­tee.

The le­gis­la­tion aims to im­prove on the fed­er­al gov­ern­ment’s latest at­tempt to make it­self more nimble in keep­ing up with sun­block tech­no­logy: a 2002 pro­ced­ur­al change from the FDA that the agency hoped would speed up its ap­prov­al pro­cess.

But without a single in­gredi­ent be­ing ap­proved since then, ad­voc­ates say it’s time for an­oth­er try.

“FDA’s goal was to cre­ate a more stream­lined pro­cess; it just didn’t work out that way,” says a staff mem­ber of the Pub­lic Ac­cess to Sun­Screens Co­ali­tion. “Every­one — melan­oma re­search­ers, the com­munity, man­u­fac­tur­ers, pa­tients, even the FDA — every­one agrees the cur­rent situ­ation is not work­ing. When you com­bine that with the in­creas­ing rates of skin can­cer, it’s a ser­i­ous pub­lic-health con­cern.”

At stake is more than sun­burns: Skin can­cer is the most com­mon form of can­cer in the United States. more than 2 mil­lion cases are dia­gnosed each year, many of which could be pre­ven­ted by pro­tect­ing the skin from sun ex­pos­ure, ac­cord­ing to the Amer­ic­an Can­cer So­ci­ety.

Con­gres­sion­al ad­voc­ates hope they can im­prove the FDA’s ex­ist­ing pro­ced­ure without upend­ing the en­tire sys­tem.

Un­der cur­rent law, if an in­gredi­ent is on the mar­ket in an­oth­er coun­try for five years, it may go through a pro­cess to be de­term­ined eli­gible by the FDA. An ad­vis­ory com­mit­tee of ex­perts then weighs in on the safety and ef­fect­ive­ness of the product, and the agency makes the fi­nal de­term­in­a­tion as to wheth­er it is ap­proved.

The Sun­screen In­nov­a­tion Act makes two primary changes to this pro­cess. First, it would in­sti­tute an eight-month dead­line for the FDA to make a de­cision, re­pla­cing a cur­rent re­view pro­cess that lacks a man­dat­ory end date. Second, the bill would no longer re­quire the FDA to is­sue a reg­u­la­tion every time it wants to ap­prove an in­gredi­ent.

The FDA de­clined to com­ment on the bill, but a spokes­per­son said the agency has “pri­or­it­ized re­view­ing the safety and ef­fect­ive­ness of ad­di­tion­al sun­screen in­gredi­ents as quickly as pos­sible giv­en the agency’s re­sources.”

This frus­tra­tion has boiled over to Cap­it­ol Hill, with match­ing House and Sen­ate bills to ad­dress the prob­lem. The House ver­sion be­ing con­sidered Monday was in­tro­duced by Re­pub­lic­an Ed Whit­field and Demo­crat John Din­gell. The Sen­ate ver­sion came from Demo­crat Jack Reed and Re­pub­lic­an Johnny Isak­son.

With back­ing from both parties, ad­voc­ates are cau­tiously op­tim­ist­ic about the bills be­com­ing law, but they re­cog­nize that bi­par­tis­an sup­port is no guar­an­tee of pas­sage — par­tic­u­larly in the cur­rent grid­locked en­vir­on­ment.

“Try­ing to pre­dict what Con­gress is go­ing to do is kind of like hav­ing a per­fect March Mad­ness brack­et,” the sun­screens co­ali­tion staff mem­ber said. “But I will say there has been tre­mend­ous bi­par­tis­an, bicam­er­al sup­port.”

What We're Following See More »
TWO MONTHS AFTER REFUSING AT CONVENTION
Cruz to Back Trump
1 days ago
THE LATEST
WHO TO BELIEVE?
Two Polls for Clinton, One for Trump
1 days ago
THE LATEST

With three days until the first debate, the polls are coming fast and furious. The latest round:

  • An Associated Press/Gfk poll of registered voters found very few voters committed, with Clin­ton lead­ing Trump, 37% to 29%, and Gary John­son at 7%.
  • A Mc­Clatchy-Mar­ist poll gave Clin­ton a six-point edge, 45% to 39%, in a four-way bal­lot test. Johnson pulls 10% support, with Jill Stein at 4%.
  • Rasmussen, which has drawn criticism for continually showing Donald Trump doing much better than he does in other polls, is at it again. A new survey gives Trump a five-point lead, 44%-39%.
NO SURPRISE
Trump Eschewing Briefing Materials in Debate Prep
1 days ago
THE DETAILS

In contrast to Hillary Clinton's meticulous debate practice sessions, Donald Trump "is largely shun­ning tra­di­tion­al de­bate pre­par­a­tions, but has been watch­ing video of…Clin­ton’s best and worst de­bate mo­ments, look­ing for her vul­ner­ab­il­it­ies.” Trump “has paid only curs­ory at­ten­tion to brief­ing ma­ter­i­als. He has re­fused to use lecterns in mock de­bate ses­sions des­pite the ur­ging of his ad­visers. He prefers spit­balling ideas with his team rather than hon­ing them in­to crisp, two-minute an­swers.”

Source:
TRUMP NO HABLA ESPANOL
Trump Makes No Outreach to Spanish Speakers
1 days ago
WHY WE CARE

Donald Trump "is on the precipice of becoming the only major-party presidential candidate this century not to reach out to millions of American voters whose dominant, first or just preferred language is Spanish. Trump has not only failed to buy any Spanish-language television or radio ads, he so far has avoided even offering a translation of his website into Spanish, breaking with two decades of bipartisan tradition."

Source:
$1.16 MILLION
Clintons Buy the House Next Door in Chappaqua
2 days ago
WHY WE CARE

Bill and Hillary Clinton have purchased the home next door to their primary residence in tony Chappaqua, New York, for $1.16 million. "By purchasing the new home, the Clinton's now own the entire cul-de-sac at the end of the road in the leafy New York suburb. The purchase makes it easier for the United States Secret Service to protect the former president and possible future commander in chief."

Source:
×